Literature DB >> 27714565

Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation.

Clairelyne Dupin1, Sylvain Marchand-Adam1,2,3, Olivier Favelle4, Romain Costes5, Philippe Gatault6, Philippe Diot1,2,3, Leslie Grammatico-Guillon5,7, Laurent Guilleminault8,9,10.   

Abstract

PURPOSE: Little is known about hypogammaglobulinemia (HGG) in asthma patients. No data are available on the characteristics of adult patients with asthma and HGG.
METHODS: We conducted a retrospective monocentric study between January 2006 and December 2012. Asthma patients with a serum immunoglobulin (Ig) quantitative analysis were included and classified into two groups depending on their serum IgG concentration: presence or absence of HGG. Clinical, biological, functional, and radiologic characteristics were compared in univariate and multivariate analysis, using a logistic regression model.
RESULTS: In univariate analysis, asthma patients with HGG (n = 25) were older (58 years old ± 18 vs 49 ± 18, p = 0.04) and more frequently active or former smokers as compared to patients with normoglobulinemia (n = 80) (56.0 vs 35.0 %, p = 0.01). Total IgE < 30 kUI/L was more frequently observed in patients with HGG (53.0 vs 18.3 %, p = 0.01). HGG asthma patients had lower fraction of exhaled nitric oxide (p = 0.02), blood eosinophilia (p = 0.0009), and presented with more severe composite score for bronchiectasis (p = 0.01). In multivariate analysis, asthma patients with HGG had increased risk of being smokers [OR = 6.11 (IC 95 % = 1.16-32.04)], having total IgE concentration < 30 kUI/L [OR = 12.87 (IC 95 % = 2.30-72.15)], and a more severe composite score of bronchiectasis [OR = 20.65 (IC 95 % = 2.13-199.74)].
CONCLUSION: Asthma patients with HGG are older and more often tobacco smoker than asthma patients without HGG. These patients have low type-2 inflammation markers.

Entities:  

Keywords:  asthma; hypogammaglobulinemia; immunoglobulin G; inflammation

Mesh:

Substances:

Year:  2016        PMID: 27714565     DOI: 10.1007/s10875-016-0335-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  46 in total

Review 1.  ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate.

Authors:  Philip E Silkoff; Serpil C Erzurum; Jon O Lundberg; Steven C George; Nandor Marczin; John F Hunt; Richard Effros; Ildiko Horvath
Journal:  Proc Am Thorac Soc       Date:  2006-04

2.  Active vaccination in patients with common variable immunodeficiency (CVID).

Authors:  S Goldacker; R Draeger; K Warnatz; D Huzly; U Salzer; J Thiel; H Eibel; M Schlesier; H H Peter
Journal:  Clin Immunol       Date:  2007-06-29       Impact factor: 3.969

3.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

Review 4.  Asthma phenotypes: the evolution from clinical to molecular approaches.

Authors:  Sally E Wenzel
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 5.  Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists.

Authors:  F Dati; G Schumann; L Thomas; F Aguzzi; S Baudner; J Bienvenu; O Blaabjerg; S Blirup-Jensen; A Carlström; P H Petersen; A M Johnson; A Milford-Ward; R F Ritchie; P J Svendsen; J Whicher
Journal:  Eur J Clin Chem Clin Biochem       Date:  1996-06

6.  Bronchial hyperreactivity in children with antibody deficiencies.

Authors:  Celal Özcan; Ayşe Metin; Mustafa Erkoçoğlu; Can Naci Kocabas
Journal:  Allergol Immunopathol (Madr)       Date:  2014-01-30       Impact factor: 1.667

Review 7.  Asthma: a syndrome composed of heterogeneous diseases.

Authors:  Larry Borish; Jeffrey A Culp
Journal:  Ann Allergy Asthma Immunol       Date:  2008-07       Impact factor: 6.347

8.  Cluster analysis and clinical asthma phenotypes.

Authors:  Pranab Haldar; Ian D Pavord; Ruth H Green; Dominic E Shaw; Michael A Berry; Michael Thomas; Christopher E Brightling; Andrew J Wardlaw
Journal:  Am J Respir Crit Care Med       Date:  2008-05-14       Impact factor: 21.405

9.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Authors:  Kian Fan Chung; Sally E Wenzel; Jan L Brozek; Andrew Bush; Mario Castro; Peter J Sterk; Ian M Adcock; Eric D Bateman; Elisabeth H Bel; Eugene R Bleecker; Louis-Philippe Boulet; Christopher Brightling; Pascal Chanez; Sven-Erik Dahlen; Ratko Djukanovic; Urs Frey; Mina Gaga; Peter Gibson; Qutayba Hamid; Nizar N Jajour; Thais Mauad; Ronald L Sorkness; W Gerald Teague
Journal:  Eur Respir J       Date:  2013-12-12       Impact factor: 16.671

Review 10.  Comparison of diagnostic criteria for common variable immunodeficiency disorder.

Authors:  Rohan Ameratunga; Maia Brewerton; Charlotte Slade; Anthony Jordan; David Gillis; Richard Steele; Wikke Koopmans; See-Tarn Woon
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

View more
  1 in total

1.  Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency.

Authors:  Joo Hee Kim; Jae Hyuk Jang; So Hee Lee; Eun Mi Yang; Seung Hun Jang; Ki Suck Jung; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.